All News

Dr. Anderson explains that the window following a cancer diagnosis represents a pivotal period for patients to make informed decisions about fertility preservation.

We are entering an era where "cure," specifically a functional cure, is no longer a forbidden word in the myeloma community.

Managing follicular lymphoma means balancing remission with the constant fear of relapse. Explore the reality of living with a chronic, incurable cancer.

Breast cancer survivor Anna Wassman-Cox discusses the Onco-Ballet Foundation and how dance provides healing and community for Stage IV patients.

New T-cell engagers and ADCs show survival gains in pretreated small cell lung cancer, signaling long-awaited progress and more treatment options for patients.

Although AI can support complex oncology decision-making, physician judgment remains critical to ensuring safe, individualized patient care.

Lauren Yerkes, founder of POST SWIM, discusses the jarring shift to breast cancer survivorship and the daily practice of reclaiming body confidence.

Columnist Linda Cohen explores the emotional toll of aging with lymphoma, the pressure of cosmetic trends, and finding beauty in enduring love.

The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III dMMR colon cancer.

Immunotherapy boosts the immune system to fight cancer but may cause skin side effects; early reporting helps manage symptoms and keep treatment on track.

Researchers identified gut microbiome markers that predict melanoma return after surgery, allowing doctors to personalize immunotherapy for patients.

Caroline Taylor discusses how disparities in access and resources affect diagnosis, treatment, and survival for patients globally.

Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with mostly mild side effects.

A colon cancer survivor shares how practicing daily gratitude and journaling helped her find peace, healing and the strength to build a vibrant life.

Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite loss and digestive issues.

Dr. Thomas Flaig discusses new therapies, biomarkers and evolving care strategies in an interview with CURE.

After a sudden collapse, a resilient cancer survivor faces a new health crisis. Through faith, PT and grit, she overcomes despair to walk again.

Dr. Sunil Dutta discusses treatment approaches and managing side effects in esophageal cancer, including nutrition and patient support strategies.

The phase 3 LITESPARK-012 trial did not improve survival in advanced kidney cancer, highlighting ongoing need for better first-line treatments.

At NCCN 2026, Dr. Charles Peyton emphasized patient engagement and shared decision-making as expanding treatment options reshape bladder cancer care.

Dr. Maryam Lustberg discusses the REVITALIZE trial testing CO2 laser therapy to treat vaginal dryness and GSM in breast cancer survivors.

A tribute to Erin Cummings, a pillar of the Hodgkin lymphome survivor community who mentored others with the wisdom and grace of a real-life Mr. Miyagi.

FDA grants Priority Review for Padcev plus Keytruda in muscle-invasive bladder cancer, showing improved survival and reduced recurrence risk.

A man with small cell lung cancer describes carboplatin-related hearing loss, fatigue and daily challenges that have reshaped his life, while holding onto perspective and resilience.

At NCCN 2026, Anjali Albanese discussed how young adults with cancer face grief, isolation and loss of control that impact their emotional well-being.

Gotistobart improved responses and survival versus docetaxel in pretreated squamous NSCLC, offering a potential chemo-free option with durable benefit in some patients.

Dr. Michael K. Wong explains why immunotherapy makes skin hypersensitive, and how to spot red-flag reactions during melanoma care.

Learn about breast angiosarcoma, a rare blood vessel cancer. Discover the signs of primary and secondary cases to help guide your oncology discussion.